Cases are 75% higher than the average, with advice on what to do if you catch it

AI search summaries show that on the same day the aurora borealis was seen across the northern hemisphere, HAARP was running experiments to artificially create aurora-like glows or "airglow" in the ionosphere. The aurora borealis, also known as the northern…

For years, China has been playing its own part in a neo-colonial struggle for influence in Africa. Rather than seeking a military footprint on the continent as, for example, the US has done, China …

In previous articles, we’ve briefly looked at data in the Disclosure UK database that related to ITVGate and an overview of payments from pharmaceutical companies to UK healthcare organisations suc…

There is not only evidence for the uselessness of much medical research: there are also sound indications that many developed countries have reached a point of over-medication which is harmful to h…

Last week, the Aligned Council of Australia held an international press conference to discuss the World Health Organisation’s proposed pandemic instruments that are due to be voted on at the 77th World Health Assembly being held at the end of this month.…

“Smart Earphones” and other “wearables” are designed to transition humans into the next stage of the surveillance state, which will be even more invasive and potentially linked to the mark of the beast. Technocrats preparing a line of 'wearable' AI devices…

On Monday, a press conference was held to launch a Japanese national movement against WHO’s pandemic plans.  Organisers also announced a protest against WHO’s plans to take place on 31 May, th…

The US Department of Health and Human Services (“HHS”) will immediately commence official debarment proceedings and implement a government-wide suspension of US taxpayer funds to EcoHealth – …

During the covid era we have already seen that certain policies which turned out to be extremely harmful were applied to people who were perceived to be “more vulnerable.” Is it possible that the u…

AstraZeneca plans to build a $1.5 billion manufacturing facility in Singapore to produce a promising category of cancer-killing drugs called antibody-drug conjugates (ADCs), the Anglo-Swedish drugmaker said on Monday.